News

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

After years of life-threatening cardiac episodes and chest pain, Cindy Mager, 59, became the first Saint Luke's patient to undergo this innovative, life-saving procedure.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

One patient's experience more than a decade ago was a pivotal moment for both Saint Luke’s Mid America Heart Institute and Saint Luke's Hospital Maternal-Fetal Medicine Program.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.